loading...

National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25)

The National Eye Institute

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

25-item version developed in 2001; 51-item version developed in 1998

The NEI-VFQ-25 is the product of an item-reduction of the longer field test version of the survey, the 51-item NEI-VFQ. The NEI-VFQ-25 also includes an appendix of additional items from the 51-item version that researchers can use to expand the scales up to 39 total items.

Authors

The National Eye Institute

Copyright
© RAND 1996
Objective
To measure the influence of visual impairment on quality of life
Therapeutic area
  • Eye Diseases
  • Nervous System Diseases
  • Pathological Conditions, Signs and Symptoms
visual impairment due to eye diseases/conditions
Therapeutic indication

Vision Disorders

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001 Jul;119(7):1050-8 (PubMed Abstract)

Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol. 1998 Nov;116(11):1496-504 (PubMed Abstract)

Parrish RK 2nd. Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma. Trans Am Ophthalmol Soc. 1996;94:919-1028 (Full Text Article)

Access this questionnaire

Permission to use the NEI-VFQ-25 is provided by the Rand Corporation without charge to all researchers provided that they identify the measure as such in all publications.
 
Users should also cite the following article:
Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001 Jul;119(7):1050-8

Specific permissions for using the NEI-VFQ-25 are detailed on the cover page of the questionnaire itself.

 

Distribution of Translations

Existing translations produced by Mapi can be obtained from Mapi Research Trust

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner

Contact and conditions of use

Authors

The National Eye Institute

- Carole M Mangione
UCLA Medical School
Department of Medicine
Los Angeles, CA 90024-1736
USA
Phone: +1 (310) 794-7280
Fax: +1 (310) 794-7399
E-mail: cmangione@mednet.ucla.edu
Carole M Mangione Publications (PubMed)
 
- Paul P Lee
Duke Eye Center
Erwin Road
Box 3802
Durham NC 27710
USA
E-mail: lee00106@mc.duke.edu
Paul P Lee Publications (PubMed)

 
Copyright Holder
 
RAND Corporation
1776 Main Street
P.O. Box 2138
Santa Monica, CA 90407-2138
USA
Phone: +1 (310) 393-0411
Fax: +1 (310) 393-4818
Website: www.rand.org

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Permission to use the NEI-VFQ-25 is provided by the Rand Corporation without charge to all researchers provided that they identify the measure as such in all publications.
 
Users should also cite the following article:
Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001 Jul;119(7):1050-8

Specific permissions for using the NEI-VFQ-25 are detailed on the cover page of the questionnaire itself.

 

Distribution of Translations

Existing translations produced by Mapi can be obtained from Mapi Research Trust

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner

Author Website(s)

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the USA

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

Interviewer-administered version

Afrikaans for South Africa*
Arabic for Egypt*
Arabic for Israel*
Arabic for Lebanon*
Bengali for India*
Bulgarian for Bulgaria*
Cantonese for Hong Kong*
Catalan for Spain*
Croatian for Croatia*
Czech for Czech Republic*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for Australia*
English for Canada*
English for Hong Kong*
English for India*
English for New Zealand*
English for Singapore*
English for South Africa*
English for the UK*
Estonian for Estonia*
Finnish for Finland*
French for Belgium*
French for Canada*
French for France*
French for Switzerland*
German for Austria*
German for Germany*
German for Switzerland*
Greek for Greece*
Gujarati for India*
Hebrew for Israel*
Hindi for India*
Hungarian for Hungary*
Italian for Italy*
Italian for Switzerland*
Japanese for Japan*
Kannada for India*
Korean for Korea*
Latvian for Latvia*
Lithuanian for Lithuania*
Malay for Singapore*
Malayalam*
Mandarin for China*
Mandarin for Hong-Kong*
Mandarin for Singapore*
Mandarin for Taiwan*
Mandarin for the USA*
Norwegian for Norway*
Oriya for India*
Polish for Poland*
Portuguese for Brazil*
Portuguese for Portugal*
Punjabi for India|#Punjabi for India*
Romanian for Romania*
Russian for Estonia*
Russian for Israel*
Russian for Latvia*
Russian for Russia*
Russian for Ukraine*
Slovak for Slovakia*
Slovenian for Slovenia*
Spanish for Argentina*
Spanish for Chile*
Spanish for Colombia*
Spanish for Mexico*
Spanish for Peru*
Spanish for Spain*
Spanish for Venezuela*
Spanish for the USA*
Swedish for Finland*
Swedish for Sweden*
Tamil for India*
Telugu for India*
Thai for Thailand*
Turkish for Turkey*
Ukrainian for Ukraine*
Urdu for India*

Self-administered version

Arabic for Algeria*
Arabic for Israel*
Arabic for Tunisia
Bengali for India*
Cantonese for Hong Kong*
Czech for Czech Republic*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for Australia*
English for Canada*
English for Ireland*
English for New Zealand*
English for Singapore*
English for South Africa*
English for the UK*
Finnish for Finland*
French for Belgium*
French for Canada*
French for France*
French for Switzerland*
French for Tunisia
German for Austria*
German for Switzerland*
Gujarati for India*
Hebrew for Israel*
Hindi for India*
Hungarian for Hungary*
Italian for Italy*
Japanese for Japan*
Kannada for India*
Korean for Korea*
Latvian for Latvia*
Lithuanian for Lithuania*
Malayalam*
Mandarin for China*
Mandarin for Singapore*
Mandarin for Taiwan*
Norwegian for Norway*
Polish for Poland*
Portuguese for Brazil*
Portuguese for Portugal*
Russian for Estonia*
Russian for Israel*
Russian for Russia*
Sesotho for South Africa*
Spanish for Argentina*
Spanish for Chile*
Spanish for Colombia*
Spanish for Mexico*
Spanish for Puerto Rico*
Spanish for Spain*
Spanish for the USA*
Swedish for Sweden*
Tamil for India*
Telugu for India*
Thai for Thailand*
Urdu for India*
* Performed by Mapi

Conditions to translate

In case further linguistic validation steps need to be performed on the translations produced by Mapi and provided by Mapi Research Trust, User shall work exclusively with Mapi. Each such upgraded version will be made available to third parties exclusively by Mapi Research Trust under the same conditions as described above.

More information on translations

Bibliographic reference of the French translation:

Nordmann JP, Viala M, Sullivan K, Arnould B, Berdeaux G. Psychometric Validation of the National Eye Institute Visual Function Questionnaire - 25 (NEI VFQ-25) French Version : In a Population of Patients Treated for Ocular Hypertension and Glaucoma. Pharmacoeconomics. 2004;22(3):197-206

 

Bibliographic references of the German translation:

Franke GH. Handbuch zum National Eye Institute Visual Function Questionnaire (NEI-VFQ) — ein psychodiagnostisches Verfahren zur Erfassung der Lebensqualität bei Sehbeeinträchtigten. 1999 Essen: Eigendruck
Franke GH, Esser J, Voigtländer A, Mähner N. Erste Ergebnisse zur psychometrischen Prüfung des NEI-VFQ (National Eye Institute Visual Function Questionnaire), eines psychodiagnostischen Verfahrens zur Erfassung der Lebensqualität bei Sehbeeinträchtigten. Zeitschrift für Medizinische Psychologie 1998; 7:178-184

 

Bibliographic reference of the Italian translation:

Rossi GC, Milano G, Tinelli C. The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: translation, validity, and reliability. J Glaucoma. 2003 Jun;12(3):213-20

 

Bibliographic reference of the Spanish for the USA translation:

Broman AT, Munoz B, West SK, Rodriguez J, Sanchez R, Snyder R, Klein R. Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: Proyecto VER. Invest Ophthalmol Vis Sci. 2001 Mar;42(3):606-13

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us